Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Burak Zeybek"'
Autor:
Emanuele Perrone, Paola Manara, Salvatore Lopez, Stefania Bellone, Elena Bonazzoli, Aranzazu Manzano, Luca Zammataro, Anna Bianchi, Burak Zeybek, Natalia Buza, Joan Tymon‐Rosario, Gary Altwerger, Chanhee Han, Gulden Menderes, Gloria S. Huang, Elena Ratner, Dan‐Arin Silasi, Masoud Azodi, Pei Hui, Peter E. Schwartz, Giovanni Scambia, Alessandro D. Santin
Publikováno v:
Molecular Oncology, Vol 14, Iss 3, Pp 645-656 (2020)
Endometrial cancer is the most common gynecologic malignancy in developed countries. The antibody–drug conjugate (ADC) sacituzumab govitecan (SG) targets trophoblast cell‐surface antigen‐2 (Trop‐2) – a cell‐surface glycoprotein highly exp
Externí odkaz:
https://doaj.org/article/4855a08bc9b94673965f1e87191a9728
Autor:
Emily M. Webster, Ghanshyam S. Yadav, Stefan Gysler, Blair McNamara, Jonathan Black, Joan Tymon-Rosario, Burak Zeybek, Chanhee Han, Christopher K. Arkfeld, Vaagn Andikyan, Gulden Menderes, Gloria Huang, Masoud Azodi, Dan-Arin Silasi, Alessandro D. Santin, Peter E. Schwartz, Elena S. Ratner, Gary Altwerger
Publikováno v:
Gynecologic Oncology Reports, Vol 34, Iss , Pp 100667- (2020)
Research within a gynecologic oncology population has lagged behind the uptake in use of medical cannabis for symptom control. This study seeks to evaluate patient experience with prescribed medical cannabis obtained through licensed dispensaries in
Externí odkaz:
https://doaj.org/article/efa0abb420a54db1b2dd8238713b1aa0
Publikováno v:
Gynecologic Oncology Reports, Vol 33, Iss , Pp 100601- (2020)
Externí odkaz:
https://doaj.org/article/1bea262b09f246bfb059a56b92d09420
Autor:
Silvia Pelligra, Natalia Buza, Pei Hui, Stefania Bellone, Burak Zeybek, Elena Ratner, Peter E. Schwartz, Giovanni Scambia, Alessandro D. Santin
Publikováno v:
Gynecologic Oncology Reports, Vol 32, Iss , Pp - (2020)
Background: Uterine serous carcinoma (USC) is an aggressive variant of endometrial cancer overexpressing HER2/neu in about 30% of cases. Trastuzumab, a humanized monoclonal antibody targeting Her2/Neu, in combination with carboplatin/paclitaxel, is c
Externí odkaz:
https://doaj.org/article/ff2bcf379200416db1549409a4ed7de8
Autor:
Emanuele Perrone, Salvatore Lopez, Burak Zeybek, Stefania Bellone, Elena Bonazzoli, Silvia Pelligra, Luca Zammataro, Aranzazu Manzano, Paola Manara, Anna Bianchi, Natalia Buza, Joan Tymon-Rosario, Gary Altwerger, Chanhee Han, Gulden Menderes, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Pei Hui, Peter E. Schwartz, Giovanni Scambia, Alessandro D. Santin
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy. Sacituzumab govitecan (SG) is a novel antibody-drug-conjugate (ADC) targeting trophoblast-antigen-2 (Trop-2), a cell surface glycoprotein highly expressed in many
Externí odkaz:
https://doaj.org/article/2f3ecf6859594b69a06c011b962dbb6a
Publikováno v:
Iranian Journal of Reproductive Medicine, Vol 9, Iss 4, Pp 295-300 (2011)
Background: The effects of estrogene on central nervous system are still controversial. Objective: We aimed to investigate the effects of raloxifene on the antioxidant enzyme [superoxide dismutase (SOD) and catalase (CAT)] activities and malondialdeh
Externí odkaz:
https://doaj.org/article/42e3cd9534a74f9bb05496035c3957c4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Histopathology; Jan2024, Vol. 84 Issue 2, p325-335, 11p
Autor:
Hüseyin Cavit Akbay, Burak Zeybek
Publikováno v:
European Journal of Education Studies. 10
Trust is the most basic need after nutrition in human life. The most basic need in business life, which is a part of human life, is trust. Employees should feel safe in their work life. Teachers who develop a sense of confidence can raise successful
Publikováno v:
Expert Opinion on Biological Therapy. 21:1087-1096
Introduction: Ovarian cancer is the deadliest gynecologic malignancy in the United States, and effective therapies for recurrent, advanced, and progressive disease are limited. Mesothelin is known ...